Praxis Precision Medicines (PRAX) Asset Utilization Ratio (2023 - 2025)

Praxis Precision Medicines' (PRAX) quarterly Asset Utilization Ratio came in at 0.02 in Q3 2025, up 369.42% year-on-year from 0.0 in Q3 2024, and up 5.43% quarter-over-quarter from 0.02 in Q2 2025.

Praxis Precision Medicines (PRAX) Asset Utilization Ratio (2023 - 2025) Analysis & Trends

Praxis Precision Medicines' Asset Utilization Ratio history runs 3 years deep, the most recent figure standing at 0.02 for Q3 2025.

  • On a quarterly basis, Asset Utilization Ratio rose 369.42% year-over-year to 0.02 in Q3 2025; TTM through Sep 2025 was 0.02, a 369.42% increase from a year earlier, with the FY2024 full-year figure at 0.03, up 24.3% from the prior year.
  • Asset Utilization Ratio grew to 0.02 in Q3 2025 per PRAX's latest filing, from 0.02 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.03 in Q4 2023 and bottomed at 0.0 in Q3 2024.
  • The 3-year median for Asset Utilization Ratio is 0.02 (2023), against an average of 0.01.
  • Across the five-year window, Asset Utilization Ratio sank 76.72% in 2024 and jumped 369.42% in 2025, its largest moves.
  • Year by year, Asset Utilization Ratio stood at 0.03 in 2023, then retreated by 24.34% to 0.02 in 2024, then retreated by 7.59% to 0.02 in 2025.
  • Per Business Quant, the three latest PRAX Asset Utilization Ratio figures stand at 0.02 (Q3 2025), 0.02 (Q2 2025), and 0.02 (Q1 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 0.69
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 0.47
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 0.37
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Praxis Precision Medicines 8.98 Bn 8.20 Bn - -

Historic Data

Download Data
DateValue
Sep 30, 2025 0.02
Jun 30, 2025 0.02
Mar 31, 2025 0.02
Dec 31, 2024 0.02
Sep 30, 2024 0.00
Jun 30, 2024 0.01
Mar 31, 2024 0.01
Dec 31, 2023 0.03
Sep 30, 2023 0.02
Jun 30, 2023 0.01
Mar 31, 2023 0.01